HCA Healthcare, Inc. (HCA)
Every FINRA and SEC series the site collects for HCA Healthcare, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as services-general medical & surgical hospitals, nec.
6.1M
Short interest
settlement 2026-08-14
5.6
Days to cover
+1.1% vs prior
75.6%
Short share of volume
2026-09-11
61,608
Fails to deliver
settlement 2026-08-13
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in HCA is 6,127,018 shares, up 300,769 shares over the last month. Over the last 48 readings it ranged from 2,595,877 shares (31 October 2024) to 6,127,018 shares (14 August 2026). The latest reading sits at the top of that range. At the reported average volume of 1.1M shares a day that is 5.6 days to cover, elevated.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/hca" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 6,127,018 | +1.1% | 1,102,584 | 5.56 |
| 2026-07-31 | 6,058,463 | +4.0% | 1,717,800 | 3.53 |
| 2026-07-15 | 5,826,249 | +8.8% | 1,864,076 | 3.13 |
| 2026-06-30 | 5,354,923 | +2.7% | 1,540,993 | 3.47 |
| 2026-06-15 | 5,214,285 | +0.0% | 1,931,748 | 2.70 |
| 2026-05-29 | 5,214,258 | +17.1% | 1,758,543 | 2.97 |
| 2026-05-15 | 4,454,149 | +2.9% | 1,225,076 | 3.64 |
| 2026-04-30 | 4,330,447 | +9.3% | 1,323,991 | 3.27 |
| 2026-04-15 | 3,963,348 | +9.3% | 825,888 | 4.80 |
| 2026-03-31 | 3,625,761 | +8.5% | 1,124,935 | 3.22 |
| 2026-03-13 | 3,342,178 | -5.7% | 1,014,821 | 3.29 |
| 2026-02-27 | 3,542,414 | -9.7% | 1,168,164 | 3.03 |
| 2026-02-13 | 3,924,877 | -5.1% | 1,175,604 | 3.34 |
| 2026-01-30 | 4,135,586 | +5.4% | 1,349,524 | 3.06 |
| 2026-01-15 | 3,922,164 | -4.9% | 948,768 | 4.13 |
| 2025-12-31 | 4,124,926 | -8.2% | 1,172,083 | 3.52 |
| 2025-12-15 | 4,495,103 | -8.8% | 1,320,832 | 3.40 |
| 2025-11-28 | 4,928,210 | +8.6% | 1,403,063 | 3.51 |
| 2025-11-14 | 4,536,300 | +12.9% | 1,261,037 | 3.60 |
| 2025-10-31 | 4,019,017 | +23.2% | 1,514,379 | 2.65 |
| 2025-10-15 | 3,263,233 | -8.4% | 1,241,661 | 2.63 |
| 2025-09-30 | 3,561,967 | -15.8% | 1,395,085 | 2.55 |
| 2025-09-15 | 4,228,281 | -1.0% | 1,190,700 | 3.55 |
| 2025-08-29 | 4,270,707 | +3.6% | 1,108,755 | 3.85 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of HCA volume is 75.6%, up 11.0 points over the last five sessions. Over the last 52 readings it ranged from 35.1% (28 July 2026) to 79.4% (8 September 2026). The latest reading sits at the top of that range. The latest reading is 10.1 points above the 30-session average of 65.5%, on 576K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 436K | 576K | 75.6% | 0 |
| 2026-09-10 | 314K | 425K | 73.8% | 22 |
| 2026-09-09 | 693K | 878K | 78.8% | 235 |
| 2026-09-08 | 503K | 633K | 79.4% | 85 |
| 2026-09-04 | 241K | 318K | 75.9% | 0 |
| 2026-09-03 | 257K | 398K | 64.6% | 0 |
| 2026-09-02 | 331K | 531K | 62.3% | 0 |
| 2026-09-01 | 287K | 487K | 58.8% | 18 |
| 2026-08-31 | 172K | 260K | 66.4% | 467 |
| 2026-08-28 | 189K | 340K | 55.7% | 0 |
| 2026-08-27 | 226K | 319K | 70.9% | 8 |
| 2026-08-26 | 212K | 391K | 54.2% | 41 |
| 2026-08-25 | 177K | 240K | 73.7% | 108 |
| 2026-08-24 | 317K | 403K | 78.7% | 2 |
| 2026-08-21 | 559K | 776K | 72.0% | 9 |
| 2026-08-20 | 192K | 345K | 55.8% | 15 |
| 2026-08-19 | 276K | 578K | 47.9% | 192 |
| 2026-08-18 | 373K | 545K | 68.4% | 14 |
| 2026-08-17 | 256K | 368K | 69.7% | 545 |
| 2026-08-14 | 185K | 343K | 53.9% | 0 |
| 2026-08-13 | 270K | 421K | 64.1% | 160 |
| 2026-08-12 | 243K | 387K | 62.7% | 1,186 |
| 2026-08-11 | 274K | 454K | 60.3% | 16 |
| 2026-08-10 | 240K | 315K | 76.1% | 20,878 |
| 2026-08-07 | 233K | 395K | 59.0% | 356 |
| 2026-08-06 | 235K | 395K | 59.4% | 51 |
| 2026-08-05 | 218K | 426K | 51.2% | 1,032 |
| 2026-08-04 | 281K | 478K | 58.8% | 0 |
| 2026-08-03 | 312K | 427K | 73.0% | 20 |
| 2026-07-31 | 225K | 354K | 63.7% | 291 |
Fails to deliver
SEC, by settlement date. JSONAs of 13 August 2026, the fails-to-deliver balance in HCA is 61,608 shares, up 61,529 shares over the last settlement date. Over the last 46 readings it ranged from 1 share (23 April 2026) to 61,608 shares (13 August 2026). The latest reading sits at the top of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-13 | 61,608 | $414.59 | $25.5M |
| 2026-08-11 | 79 | $414.03 | $33K |
| 2026-08-07 | 74 | $408.89 | $30K |
| 2026-08-03 | 69 | $402.59 | $28K |
| 2026-07-23 | 77 | $371.87 | $29K |
| 2026-07-01 | 6 | $389.89 | $2K |
| 2026-06-29 | 2 | $391.68 | $783 |
| 2026-06-25 | 4,808 | $387.76 | $1.9M |
| 2026-06-17 | 44 | $396.93 | $17K |
| 2026-06-15 | 1,179 | $387.18 | $456K |
| 2026-06-08 | 2,349 | $372.13 | $874K |
| 2026-04-24 | 25 | $474.03 | $12K |
| 2026-04-23 | 1 | $471.34 | $471 |
| 2026-04-17 | 361 | $482.97 | $174K |
| 2026-04-16 | 310 | $488.58 | $151K |
| 2026-04-08 | 2,569 | $489.58 | $1.3M |
| 2026-03-25 | 15 | $485.72 | $7K |
| 2026-03-23 | 18 | $493.88 | $9K |
| 2026-03-11 | 13 | $537.64 | $7K |
| 2026-03-10 | 4,807 | $545.13 | $2.6M |
| 2026-03-05 | 27,203 | $544.41 | $14.8M |
| 2026-02-20 | 328 | $528.66 | $173K |
| 2026-02-19 | 9 | $535.02 | $5K |
| 2026-02-10 | 380 | $497.54 | $189K |
| 2026-02-06 | 400 | $513.76 | $206K |
| 2026-02-05 | 10 | $493.64 | $5K |
| 2026-01-21 | 3,724 | $464.38 | $1.7M |
| 2026-01-20 | 6,186 | $469.29 | $2.9M |
| 2026-01-14 | 2 | $479.32 | $959 |
| 2026-01-05 | 7,848 | $470.39 | $3.7M |
Insider trades
SEC Form 4, newest first, 50 of 60 shown. JSONNo open-market insider trades were reported for HCA in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: McAlevey Michael R (EVP & Chief Legal & Admin Off.) on 2026-08-26.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | J | 8K | $429.00 | $3.3M | 0 |
| 2026-05-07 | Marks Mike A | EVP and CFO | Gift | 3K | $0.00 | $0 | 0 |
| 2026-04-28 | Smith Andrea B | n/a | Grant | 509 | $0.00 | $0 | 5K |
| 2026-04-28 | Riley Wayne Joseph | n/a | Grant | 509 | $0.00 | $0 | 15K |
| 2026-04-28 | MICHELSON MICHAEL W | n/a | Grant | 925 | $0.00 | $0 | 13K |
| 2026-04-28 | Johnston Hugh F | n/a | Grant | 809 | $0.00 | $0 | 4K |
| 2026-04-28 | Frist William R | n/a | Grant | 809 | $0.00 | $0 | 14K |
| 2026-04-28 | FRIST THOMAS F III | n/a | Grant | 1K | $0.00 | $0 | 16K |
| 2026-04-28 | DEPARLE NANCY ANN | n/a | Grant | 509 | $0.00 | $0 | 22K |
| 2026-04-28 | CHIDSEY JOHN | n/a | Grant | 809 | $0.00 | $0 | 1K |
| 2026-02-18 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | Sell | 2K | $533.37 | $904K | 9K |
| 2026-02-13 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | Tax withholding | 3K | $540.29 | $1.8M | 11K |
| 2026-02-13 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | Option exercise | 5K | $236.61 | $1.2M | 14K |
| 2026-02-11 | Wyatt Christopher F. | SVP & Controller | Sell | 4K | $505.00 | $2.0M | 44K |
| 2026-02-11 | Berres Jennifer | SVP & Chief Human Res. Officer | Sell | 4K | $503.00 | $2.0M | 16K |
| 2026-02-10 | Wyatt Christopher F. | SVP & Controller | Tax withholding | 1K | $502.05 | $519K | 48K |
| 2026-02-10 | Wyatt Christopher F. | SVP & Controller | Grant | 3K | $0.00 | $0 | 49K |
| 2026-02-10 | Rossitto Erica | SVP & Chief Nurse Executive | Tax withholding | 418 | $502.05 | $210K | 10K |
| 2026-02-10 | Rossitto Erica | SVP & Chief Nurse Executive | Grant | 2K | $0.00 | $0 | 11K |
| 2026-02-10 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | Tax withholding | 3K | $502.05 | $1.5M | 9K |
| 2026-02-10 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | Grant | 8K | $0.00 | $0 | 12K |
| 2026-02-10 | Marks Mike A | EVP and CFO | Tax withholding | 2K | $502.05 | $848K | 3K |
| 2026-02-10 | Marks Mike A | EVP and CFO | Grant | 5K | $0.00 | $0 | 5K |
| 2026-02-10 | HAZEN SAMUEL N | CEO | Tax withholding | 21K | $502.05 | $10.7M | 65K |
| 2026-02-10 | HAZEN SAMUEL N | CEO | Grant | 55K | $0.00 | $0 | 86K |
| 2026-02-10 | Foster Jon M | EVP and COO | Tax withholding | 6K | $502.05 | $3.0M | 23K |
| 2026-02-10 | Foster Jon M | EVP and COO | Grant | 16K | $0.00 | $0 | 29K |
| 2026-02-10 | Cuffe Michael S. | EVP and Chief Clinical Officer | Tax withholding | 4K | $502.05 | $1.8M | 32K |
| 2026-02-10 | Cuffe Michael S. | EVP and Chief Clinical Officer | Grant | 10K | $0.00 | $0 | 36K |
| 2026-02-10 | Berres Jennifer | SVP & Chief Human Res. Officer | Tax withholding | 3K | $502.05 | $1.3M | 20K |
| 2026-02-10 | Berres Jennifer | SVP & Chief Human Res. Officer | Grant | 7K | $0.00 | $0 | 23K |
| 2026-02-06 | HERCULES HOLDING II | n/a | J | 36.6M | $0.00 | $0 | 32.3M |
| 2026-02-05 | Wyatt Christopher F. | SVP & Controller | Tax withholding | 6K | $513.76 | $2.9M | 46K |
| 2026-02-05 | Wyatt Christopher F. | SVP & Controller | Option exercise | 11K | $139.06 | $1.5M | 52K |
| 2026-02-05 | Foster Jon M | EVP and COO | Tax withholding | 16K | $513.76 | $8.3M | 13K |
| 2026-02-05 | Foster Jon M | EVP and COO | Option exercise | 29K | $139.06 | $4.1M | 29K |
| 2026-02-04 | HAZEN SAMUEL N | CEO | J | 1K | $498.35 | $521K | 31K |
| 2026-02-03 | HAZEN SAMUEL N | CEO | Sell | 120 | $497.18 | $60K | 32K |
| 2026-02-03 | HAZEN SAMUEL N | CEO | Sell | 4K | $498.12 | $2.1M | 32K |
| 2026-02-03 | HAZEN SAMUEL N | CEO | Sell | 5K | $498.80 | $2.6M | 37K |
| 2026-02-03 | HAZEN SAMUEL N | CEO | Sell | 6K | $500.02 | $3.1M | 42K |
| 2026-02-03 | HAZEN SAMUEL N | CEO | Sell | 7K | $500.69 | $3.7M | 48K |
| 2026-02-03 | HAZEN SAMUEL N | CEO | Sell | 5K | $502.15 | $2.5M | 55K |
| 2026-02-03 | HAZEN SAMUEL N | CEO | Sell | 15K | $502.95 | $7.4M | 60K |
| 2026-02-03 | Cuffe Michael S. | EVP and Chief Clinical Officer | Gift | 4K | $0.00 | $0 | 26K |
| 2026-02-03 | Cuffe Michael S. | EVP and Chief Clinical Officer | Sell | 2K | $498.09 | $747K | 30K |
| 2026-01-30 | HAZEN SAMUEL N | CEO | Tax withholding | 41K | $488.27 | $20.3M | 75K |
| 2026-01-30 | HAZEN SAMUEL N | CEO | Option exercise | 84K | $81.96 | $6.9M | 117K |
| 2025-11-14 | HAZEN SAMUEL N | CEO | Gift | 15K | $0.00 | $0 | 32K |
| 2025-11-05 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | Sell | 4K | $473.79 | $1.8M | 3K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
13F holders
Tracked managers holding HCA at their latest 13F. JSON9 of the 30 tracked managers held HCA at their latest 13F, $557.0M in total at quarter-end prices. Citadel Advisors is the largest at $234.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 602K | $234.8M | 0.03% | -4K |
| AQR Capital Management | 2026-06-30 | 225K | $87.6M | 0.03% | -105K |
| Bridgewater Associates | 2026-06-30 | 203K | $79.2M | 0.33% | +29K |
| Millennium Management | 2026-06-30 | 165K | $64.2M | 0.02% | -2K |
| D. E. Shaw & Co. | 2026-06-30 | 163K | $63.6M | 0.03% | +100K |
| Point72 Asset Management | 2026-06-30 | 44K | $17.0M | 0.02% | +17K |
| Renaissance Technologies | 2026-06-30 | 19K | $7.3M | 0.01% | +6K |
| Two Sigma Investments | 2026-06-30 | 5K | $2.1M | 0.00% | +4K |
| Fisher Asset Management | 2026-06-30 | 3K | $1.2M | 0.00% | +1K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q1 2026 (quarter ended 2026-03-31) HCA Healthcare, Inc. reported revenue of $19.11B, up 4.3% from the same quarter a year earlier, and net income of $1.62B (7.15 diluted EPS). In FY 2025 it generated $12.64B of operating cash flow and spent $10.07B on buybacks and $679.0M on dividends. As of 2026-03-31, cash was $940.0M against $44.37B of debt.
- Cash
- $940.0M
- Debt
- $44.37B
- Equity
- -$6.30B
- Total assets
- $61.45B
- Shares outstanding
- 221,839,800
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $19.11B | $1.62B | 8.5% | 7.15 |
| Q4 2025derived | 2025-12-31 | $19.51B | $1.88B | 9.6% | n/a |
| Q3 2025 | 2025-09-30 | $19.16B | $1.64B | 8.6% | 6.96 |
| Q2 2025 | 2025-06-30 | $18.61B | $1.65B | 8.9% | 6.83 |
| Q1 2025 | 2025-03-31 | $18.32B | $1.61B | 8.8% | 6.45 |
| Q4 2024derived | 2024-12-31 | $18.29B | $1.44B | 7.9% | n/a |
| Q3 2024 | 2024-09-30 | $17.49B | $1.27B | 7.3% | 4.88 |
| Q2 2024 | 2024-06-30 | $17.49B | $1.46B | 8.4% | 5.53 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $75.60B | $6.78B | $12.64B | $4.94B | $10.07B | $679.0M |
| FY 2024 | 2024-12-31 | $70.60B | $5.76B | $10.51B | $4.88B | $6.04B | $690.0M |
| FY 2023 | 2023-12-31 | $64.97B | $5.24B | $9.43B | $4.74B | $3.81B | $661.0M |
| FY 2022 | 2022-12-31 | $60.23B | $5.64B | $8.52B | $4.39B | $7.00B | $653.0M |
| FY 2021 | 2021-12-31 | $58.75B | $6.96B | $8.96B | $3.58B | $8.21B | $624.0M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-03-31; shares outstanding as of 2026-04-27 from the cover page.
What this page is
HCA Healthcare, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows HCA Healthcare, Inc. (HCA), SEC CIK 860730, listed on NYSE, classified by the SEC as services-general medical & surgical hospitals, nec. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-13.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-03-31.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-26.JSON and CSV
- Company record
- EDGAR filing index for CIK 860730Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-general medical & surgical hospitals, nec
- UHSUNIVERSAL HEALTH SERVICES INC
- CRWVCoreWeave, Inc.
- UTHRUNITED THERAPEUTICS Corp
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRWDCrowdStrike Holdings, Inc.
- RCGRENN Fund, Inc.
- APPAppLovin Corp
- SESea Ltd
- VICRVICOR CORP
- GOOGLAlphabet Inc.
- ANETArista Networks, Inc.
- CRMSalesforce, Inc.
- RDDTReddit, Inc.
- CRDOCredo Technology Group Holding Ltd
- NVDANVIDIA CORP
- METAMeta Platforms, Inc.
- STXSeagate Technology Holdings plc
- APPFAPPFOLIO INC
- ALABAstera Labs, Inc.
- IOTSamsara Inc.
- DASHDoorDash, Inc.
- WALWESTERN ALLIANCE BANCORPORATION
- HSYHERSHEY CO
Datasets
Frequently Asked Questions
How much of HCA is sold short?
What is HCA's daily short volume?
Does HCA have fails to deliver?
Are HCA insiders buying or selling?
What did HCA report last quarter?
Which funds hold HCA?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.